Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Forecasted Market Size Estimates For The COVID-19 Saliva Screening Test Potential Market Between 2025 And 2029?
The covid-19 saliva screening test potential market size has experienced robust growth in recent years. It is anticipated to expand from $3.9 billion in 2024 to $4.28 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.7%. This historic expansion can be attributed to factors like the prospect of home testing, an extraordinary demand for diagnostic testing, heightened public awareness, and investment in research and development.
The market for COVID-19 saliva screening tests is projected to experience substantial expansion over the coming years. By 2029, this market is anticipated to reach “$6.03 billion, demonstrating a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this growth during the projection period include its incorporation into screening initiatives, supportive regulations, the rising need for rapid, point-of-care COVID-19 diagnostics, an expanding global population, and the expansion of e-commerce. Key trends for the upcoming period encompass wider usage outside traditional healthcare environments, harmonization with digital health systems, the emergence of advanced technological solutions, general technological progress, and collaborative strategic alliances.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16026&type=smp
What Are The Top Growth Drivers Impacting The COVID-19 Saliva Screening Test Potential Market Outlook?
The rising spending on healthcare is anticipated to drive the expansion of the COVID-19 saliva screening test potential market in the future. This expenditure encompasses the total funds allocated to healthcare products and services, such as prescription medications, hospitalizations, doctor consultations, medical apparatus, and public health initiatives. Various factors contribute to the growth in healthcare spending, including the adoption of minimally invasive surgical procedures, advanced diagnostic instruments, heightened research and development for new pharmaceuticals, increased use of healthcare facilities, and specialized medicines. Elevated healthcare expenditure facilitates the provision of essential resources and backing needed to fully utilize COVID-19 saliva screening tests, thereby aiding in more efficient pandemic control and improved public health results. As an illustration, figures from the Office for National Statistics, a UK-based national statistics organization, revealed that the UK’s healthcare expenditure reached approximately $354.88 billion (£283 billion) in 2022, marking a nominal increase of 0.7% compared to the spending in 2021. Consequently, the upward trend in healthcare expenditure is fueling the expansion of the COVID-19 saliva screening test potential market.
How Is The COVID-19 Saliva Screening Test Potential Market Classified Into Different Segments?
The covid-19 saliva screening test potentialmarket covered in this report is segmented –
1) By Location: Travel Stations; Sports Arenas; Entertainment Venues; Corporate Campus Environments; Universities And Colleges; Factories; Other Locations
2) By Technology: Fluorescence-Labelled Antigen; RT-PCR; CRISPR-Cas9
3) By Mode Of Testing: Centralized Testing; Decentralized Testing
Subsegments:
1) By Travel Stations: Airports; Train Stations; Bus Stations; Seaports
2) By Sports Arenas: Stadiums; Arenas; Event Halls
3) By Entertainment Venues: Theaters; Concert Halls; Amusement Parks; Nightclubs
4) By Corporate Campus Environments: Offices; Corporate Campuses; Business Parks
5) By Universities And Colleges: Higher Education Campuses; Research Institutions; Student Housing Areas
6) By Factories: Manufacturing Plants; Production Facilities; Industrial Sites
7) By Other Locations: Healthcare Facilities; Government Buildings; Public Transportation Hubs; Shopping Centers; Other Public Or Private Venues
Which Market Trends Are Creating New Opportunities In The COVID-19 Saliva Screening Test Potential Industry?
Major companies operating within the COVID-19 saliva screening test potential market are focusing on developing innovative technologies, such as data-sharing platforms, to enhance real-time communication and collaboration among healthcare providers, laboratories, and public health authorities. This effort aims to ultimately improve the efficiency and accuracy of testing, tracking, and response efforts during the pandemic. Data-sharing platforms are digital systems that facilitate the secure exchange of data among various stakeholders, including healthcare providers, researchers, and organizations. They promote collaboration and information access to improve decision-making, efficiency, and outcomes across sectors. For instance, in May 2024, Mount Sinai Health System, a US-based healthcare network, inaugurated the Center for Healthcare Readiness. This Center is dedicated to improving strategies for public health emergency response, ensuring that healthcare systems can effectively manage large-scale crises such as pandemics or natural disasters. It endeavors to enhance the capacity of the Mount Sinai Health System and collaborate with local, regional, and federal partners to develop comprehensive preparedness plans.
Which Leading Players Are Enhancing Their COVID-19 Saliva Screening Test Potential Market Presence Worldwide?
Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.
Download The Full Report For Exclusive Market Findings:
How Is COVID-19 Saliva Screening Test Potential Market Demand Varying Across Different Regions?
North America was the largest region in the COVID-19 saliva screening test potential market in 2024. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The COVID-19 Saliva Screening Test Potential Market Report:
https://www.thebusinessresearchcompany.com/customise?id=16026&type=smp
Browse Through More Reports Similar to the Global COVID-19 Saliva Screening Test Potential Market 2025, By The Business Research Company
Drug Screening Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report
Security Screening Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report
Employment Screening Services Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/employment-screening-services-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model